Acadian Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.15M	Buy	99,109 +5,610	+6%	+$109K	﹤0.01%	936
2025 Q4	$2.01M	Buy	93,499 +68,197	+270%	+$1.44M	﹤0.01%	910
2025 Q3	$483K	Buy	+25,302	New	+$451K	﹤0.01%	1231
2024 Q3	–	Sell	-8,566	Closed	-$1.35M	–	2320
2024 Q2	$1.35M	Buy	+8,566	New	+$1.1M	﹤0.01%	894
2024 Q1	–	Sell	-1,879	Closed	-$180K	–	1774
2023 Q4	$180K	Buy	+1,879	New	+$180K	﹤0.01%	1252
2023 Q3	–	Sell	-498	Closed	-$57K	–	1832
2023 Q2	$57K	Sell	498 -494	-50%	-$63.7K	﹤0.01%	1509
2023 Q1	$136K	Buy	992 +100	+11%	+$13K	﹤0.01%	1336
2022 Q4	$115K	Sell	892 -4,384	-83%	-$508K	﹤0.01%	1405
2022 Q3	$581K	Buy	5,276 +2,271	+76%	+$229K	﹤0.01%	951
2022 Q2	$224K	Buy	+3,005	New	+$221K	﹤0.01%	1172
2022 Q1	–	Sell	-5,683	Closed	-$510K	–	1788
2021 Q4	$510K	Sell	5,683 -1,001	-15%	-$85.6K	﹤0.01%	1006
2021 Q3	$617K	Buy	+6,684	New	+$515K	﹤0.01%	983
2021 Q2	–	Sell	-3,819	Closed	-$285K	–	2197
2021 Q1	$285K	Buy	+3,819	New	+$352K	﹤0.01%	1382
2020 Q3	–	Sell	-173	Closed	-$28K	–	2347
2020 Q2	$28K	Buy	+173	New	+$23.5K	﹤0.01%	2065